The spindle assembly checkpoint (SAC) is a conserved mechanism that ensures the fidelity of chromosome distribution in mitosis by preventing anaphase onset until the correct bipolar microtubule-kinetochore attachments are formed. Errors in SAC function may contribute to
tumorigenesis by inducing numerical chromosome anomalies (
aneuploidy). On the other hand, total disruption of SAC can lead to massive genomic imbalance followed by cell death, a phenomena that has therapeutic potency. We performed a cell-based high-throughput screen with a compound library of 2000 bioactives for novel SAC inhibitors and discovered a plant-derived phenolic compound
eupatorin (3',5-dihydroxy-4',6,7-trimethoxyflavone) as an anti-mitotic
flavonoid. The premature override of the microtubule
drug-imposed mitotic arrest by
eupatorin is dependent on microtubule-kinetochore attachments but not interkinetochore tension.
Aurora B kinase activity, which is essential for maintenance of normal SAC signaling, is diminished by
eupatorin in cells and in vitro providing a mechanistic explanation for the observed forced mitotic exit.
Eupatorin likely has additional targets since
eupatorin treatment of pre-mitotic cells causes spindle anomalies triggering a transient M phase delay followed by impaired cytokinesis and
polyploidy. Finally,
eupatorin potently induces apoptosis in multiple
cancer cell lines and suppresses
cancer cell proliferation in organotypic 3D cell culture model.